In Depth 20 Sep 2024 Mitigating hot flashes: new therapies for menopause on the rise New therapies could address menopause symptoms, a field in which many treatment gaps still exist. September 20, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 19 Sep 2024 Mitochondrial disease treatments: is a breakthrough on the horizon? Mitochondrial dysfunction is linked to many diseases. Discover how biotechs are developing mitochondrial disease treatments to address these diseases. September 19, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 12 Sep 2024New treatments being developed for schizophrenia Explore the latest strides in schizophrenia treatment development as 2024 heralds a pivotal year, with promising collaborations and trials. September 12, 2024 Share WhatsApp Twitter Linkedin Email
News and Trends 10 Sep 2024 Long non-coding RNAs: what’s behind the growing “dark genome” buzz? Recent deals have zoned in on drugs that target long non-coding RNAs and major moves are currently being made on the R&D front. September 10, 2024 - 5 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Sep 2024 Six biotech companies that could revolutionize obesity treatments In this article, we take a look at six biotechs focused on bringing drugs to treat obesity to the market. September 5, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 4 Sep 2024 2024: a year of breakthroughs for endometrial cancer? New treatments have been approved by regulators for endometrial cancer, which are regarded as major therapeutic breakthroughs. September 4, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 28 Aug 2024 GLP-1 shortage: Can biotech companies keep up with rising demand? How is the biotech industry responding to the GLP-1 drug shortage? We asked experts in the field to answer this question. August 28, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 20 Aug 2024 Fighting mpox: promising vaccines to watch As Bavarian Nordic ramps up production of the only marketed mpox vaccine, a few clinical trials are underway to combat the outbreak. August 20, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 14 Aug 2024 CAR-T drugs and parkinsonism: a cause for concern? CAR-T therapies come with boxed warnings of serious neurotoxic side effects. Now, growing concerns over parkinsonism have led to a clinical trial halt. August 14, 2024 - 3 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 13 Aug 2024 Biologics vs. drugs: What does Ipsen’s lost case against the FDA mean for the industry? Ipsen has lost a court case against U.S. regulators to have its blockbuster cancer medication Somatuline Depot regarded as a biologic instead of a drug. August 13, 2024 - 4 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 2 Aug 2024 Six epigenetics companies making strides in 2024 In this article, we take a look at six epigenetics companies that are significant as well as up-and-coming players in the industry. August 2, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 1 Aug 2024 European regulators reject Alzheimer’s drug Leqembi: is it downhill from here? European regulators have now refused to market the Alzheimer’s drug Leqembi after it was approved by the FDA last year. August 1, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email